title: Advances in sentinel lymph node mapping for patients with melanoma.
abstract: Sentinel lymph node mapping allows accurate pathological staging for patients with cutaneous melanoma and clinically normal regional nodes. Early technical advances facilitated its widespread acceptance by surgeons. Morbidity as a result of the procedure is well established, but the potential benefit of providing powerful prognostic information outweighs these risks in most patients with intermediate-risk disease.
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, Weill-Cornell School of Medicine, New York, NY, USA. bradym@mskcc.org
authors.forename: Mary S
authors.initials: MS
authors.lastname: Brady
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000175:diagnosis*; D009367:Neoplasm Staging; D011379:Prognosis; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000175:diagnosis*